This topic contains a solution. Click here to go to the answer

Author Question: Technetium-99m, xenon-133, and gallium-67 are radiopharmaceutical drugs that ________. A) emit ... (Read 62 times)

s.tung

  • Hero Member
  • *****
  • Posts: 577
Technetium-99m, xenon-133, and gallium-67 are radiopharmaceutical drugs that ________.
 
  A) emit positrons
  B) are combined with monoclonal antibodies
  C) contain iodine
  D) emit gamma rays

Question 2

The superior end of the spinal cord attaches to the cerebellum of the brain.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dajones82

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

D
Explanation: A) These drugs do not emit positrons.
B) These drugs are not combined with monoclonal antibodies.
C) These drugs do not contain iodine.
D) Correct

Answer to Question 2

FALSE
Explanation: The superior end of the spinal cord attaches to, and is continuous with, the medulla oblongata of the brainstem.




s.tung

  • Member
  • Posts: 577
Reply 2 on: Jun 27, 2018
Wow, this really help


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

For a complete list of videos, visit our video library